Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  1992-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp.55.2.126PMID 1538217PMCID PMC488975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Viloxazine: A Review of Its Pharmacological Properties and Therapeutic Efficacy in Depressive Illness

  2012cited by this paper
• Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment

  2004cited by this paper
• Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: Pharmacological and pharmacokinetic studies in rodents and the epileptic baboon

  2004cited by this paper
• Carbamazepine-viloxazine interaction in patients with epilepsy.

  1986cited by this paper
• Seizures with Antidepressants: An In Vitro Technique to Assess Relative Risk

  1984cited by this paper
• Effect of Viloxazine on Serum Carbamazepine Levels in Epileptic Patients

  1984cited by this paper
• Does viloxazine have epileptogenic properties?

  1984cited by this paper
• Pharmacokinetic Interactions of Antiepileptic Drugs

  1984cited by this paper
• Pharmacokinetic Interactions with Antiepileptic Drugs

  1982cited by this paper
• Drug Interactions with Phenytoin

  1981cited by this paper

• Pharmacokinetic Interactions Between Antiseizure and Psychiatric Medications

  2022influential citation
• New-generation, non-SSRI antidepressants: Drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others.

  2020cites this paper
• Clinically Significant Drug–Drug Interactions with Agents for Attention-Deficit/Hyperactivity Disorder

  2019cites this paper
• Hepatitis C virus: Morphogenesis, infection and therapy

  2018cites this paper
• Phenytoin

  2018cites this paper
• Simple, convergent synthesis of the pyrazole linked pyridine derivatives: Micro-wave, sonication and conventional methods

  2013cites this paper
• Anticonvulsants - antidepressants pharmacokinetic drug interactions: the role of the CYP450 system in psychopharmacology.

  2008cites this paper
• Mood disorders in patients with epilepsy.

  2007cites this paper
• Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings

  2003cites this paper
• Noradrenalin-selektive Antdeessva(NRI)

  2002cites this paper
• Clinical Significance of Pharmacokinetic Interactions Between Antiepileptic and Psychotropic Drugs

  2002cites this paper
• Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism

  2002cites this paper
• Interactions Between Anticonvulsant and Psychoactive Drugs

  1999cites this paper
• Metabolism of Some “Second”– and “Fourth”–Generation Antidepressants: Iprindole, Viloxazine, Bupropion, Mianserin, Maprotiline, Trazodone, Nefazodone, and Venlafaxine

  1999cites this paper
• Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance.

  1998cites this paper
• Treatment of Concomitant Illneses in Patients Receiving Anticonvulsants

  1998cites this paper
• Oxcarbazepine: Pharmacokinetic Interactions and Their Clinical Relevance

  1994cites this paper
• Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy

  1994cites this paper
• [Theophylline overdose following a treatment with viloxazine].

  1994cites this paper
• Newer and Older Antidepressants

  1994cites this paper
• SURDOSAGE EN THEOPHYLLINE SECONDAIRE A UN TRAITEMENT PAR VILOXAZINE

  1994cites this paper
• Nicht-trizyklische Antidepressiva

  1993cites this paper
• [Does a metabolic interaction exist between viloxazine and antivitamins K?].

  1993cites this paper
• Carbamazepine coadministration with fluoxetine or fluvoxamine.

  1993cites this paper